AstraZeneca Pharma India gets CDSCO nod to import and market datverzo breast cancer drug
Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) is indicated for the treatment of adult patients with unresectable or metastatic, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. Shares of Astrazeneca Pharma India Ltd ended at ₹8,984.50, down by ₹32.00, or 0.35%, on the BSE.
BoB underwrites $500 million forex loan facility to ONGC unit
Coursera to acquire Udemy in $2.5 billion all-stock deal
Under the terms of the deal, Udemy shareholders will receive 0.8 shares of Coursera for every share held. The deal implies an acquisition price of approximately $6.35 per Udemy share — a 26% premium over the 30-day average closing price
Cyient Semiconductors acquires majority stake in Kinetic Technologies for $93 million
The development is expected to accelerate growth across various sectors, including data centers, electrification, automotive, networking, industrial automation, and the emerging edge AI compute segment
PFRDA eases withdrawal norms for private subscribers; exit age raised to 85 - top thing to know
India's pension regulator has significantly relaxed exit and withdrawal norms for National Pension System (NPS) non-government subscribers, allowing them to withdraw up to 80% of their pension wealth. The investment horizon has also been extended to age 85 for all categories, offering greater flexibility in retirement planning.
India-Oman trade deal: How the CEPA will anchor India’s expanding Gulf strategy; strengthen strategic and investment footprint
India and Oman are set to sign a Comprehensive Economic Partnership Agreement on December 18, aiming to deepen economic ties and expand India's trade and strategic footprint in the Gulf. The pact will cover goods, services, and investment, reducing tariffs and facilitating business, while also carrying significant geopolitical weight.
UGRO Capital's panel approves ₹500-crore NCD issue via private placement
The Investment and Borrowing Committee cleared the base issue size of up to ₹200 crore, with an option to retain oversubscription of up to ₹300 crore under a green shoe option. Shares of Ugro Capital Ltd ended at ₹171.20, down by ₹0.22, or 0.13%, on the BSE today, December 17.
Sukanya Samriddhi Yojana: At 8.2% interest rate, is SSY the right savings scheme for your girl child? Explained
Sukanya Samriddhi Yojana (SSY) offers a government-backed 8.2% tax-free interest for girl children, aiming to fund their future education or marriage. While a secure fixed-income option, experts suggest combining it with equity investments for better inflation-beating returns over its 21-year maturity period.
US stocks inch up as investors eye monetary policy outlook
Wall Street indexes traded higher in volatile sessions as investors sought interest rate outlook clues. Oracle shares dipped amid funding concerns for its data center plans, impacting the tech sector's AI ambitions. Energy stocks rebounded, while Netflix saw gains following reports of a potential OpenAI investment.
MoEngage’s Series F swells to $280 mn, eyes AI expansion and acquisitions
MoEngage has secured an additional $180 million in Series F funding, bringing the total to $280 million. The investment will support its AI product development and expand operations in North America and Europe.
Warner Bros asks investors to reject takeover bid from Paramount Skydance
Paramount’s attempt to buy Warner’s cable networks and news business would also bring CBS and CNN under the same roof